Molecular Data Stock Forecast, Price & News

Wall Street analysts have given Molecular Data a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Molecular Data wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Molecular Data saw a decline in short interest in the month of August. As of August 13th, there was short interest totaling 1,920,000 shares, a decline of 27.3% from the July 29th total of 2,640,000 shares. Based on an average trading volume of 1,230,000 shares, the short-interest ratio is presently 1.6 days. Currently, 1.8% of the shares of the company are short sold.
View Molecular Data's Short Interest.

Molecular Data's stock was trading at $1.89 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MKD shares have decreased by 82.5% and is now trading at $0.3299.
View which stocks have been most impacted by COVID-19.

Some companies that are related to Molecular Data include RTCORE (PPPS), RTCORE (RTME), Diginex (EQOS), Net Savings Link (NSAV), Future FinTech Group (FTFT), PaySign (PAYS), Quhuo (QH), Augmedix (AUGX), ServiceSource International (SREV), Steel Connect (STCN), Marchex (MCHX), Waitr (WTRH), MOGU (MOGU), Ucommune International (UK) and Heritage Global (HGBL).
View all of MKD's competitors.

(MKD) raised $69 million in an initial public offering (IPO) on the week of December 30th 2019. The company issued 11,500,000 shares at $5.00-$7.00 per share. AMTD, Fosun Hani and Boustead Securities served as the underwriters for the IPO and Tiger Brokers and Guotai Junan International were co-managers.

Molecular Data trades on the NASDAQ under the ticker symbol "MKD."

Molecular Data's stock is owned by many different institutional and retail investors. Top institutional investors include Citadel Advisors LLC (0.11%).

MKD stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC.

Shares of MKD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MKD stock can currently be purchased for approximately $0.33.

Molecular Data has a market capitalization of $49.00 million and generates $1.16 billion in revenue each year.

Molecular Data employs 189 workers across the globe.

The official website for Molecular Data is www.molbase.cn.

Molecular Data is headquartered at 5/F BUILDING 12 1001 NORTH QINZHOU ROAD XUHUI DISTRICT, SHANGHAI F4, 201109.

Molecular Data's mailing address is 5/F BUILDING 12 1001 NORTH QINZHOU ROAD XUHUI DISTRICT, SHANGHAI F4, 201109. The company can be reached via phone at 86-21-5436-5166 or via email at [email protected]